Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 7/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 7/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.43 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5697471 | 0.86 | MBOAT4 (0.51) | MBOAT4GRIN1GRIN2BCYP19A1CDK5 | |
| SCHEMBL5697473 | 0.86 | MBOAT4 (0.51) | MBOAT4GRIN1GRIN2BCYP19A1CDK5 | |
| SCHEMBL28050395 | 0.82 | MBOAT4 (0.35) | MBOAT4GRIN1GRIN2BCYP19A1 | |
| SCHEMBL9129627 | 0.80 | CYP19A1 (0.54) | CYP19A1 | |
| SCHEMBL9129634 | 0.80 | CYP19A1 (0.54) | CYP19A1 | |
| SCHEMBL4442662 | 0.78 | CYP19A1 (0.57) | CYP19A1 | |
| SCHEMBL21807748 | 0.78 | CYP19A1 (0.57) | CYP19A1 | |
| SCHEMBL147012 | 0.78 | CYP19A1 (0.57) | CYP19A1 | |
| SCHEMBL28050394 | 0.78 | CYP19A1 (0.57) | CYP19A1 | |
| SCHEMBL1650440 | 0.78 | CYP19A1 (0.57) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0217840-B1 | PROCESS FOR THE PRODUCTION OF 1-METHYL-1,4-ANDROSTADIEN-3,17-DION | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-12-13 | — | — | EP | claimed |
| EP-0768896-A2 | LOW-DOSE STEROID TABLETS CONTAINING GALLIC ACID ESTERS AS ANTIOXIDANT AGENT, PROCESS FOR THE MANUFACTURE OF SAID TABLETS, AND USES OF SAID TABLETS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-04-23 | — | — | EP | disclosed |
| WO-1996001128-A2 | LOW-DOSE STEROID TABLETS CONTAINING GALLIC ACID ESTERS AS ANTIOXIDANT AGENT, PROCESS FOR THE MANUFACTURE OF SAID TABLETS, AND USES OF SAID TABLETS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-01-18 | — | — | WO | disclosed |